Fusion Pharmaceuticals Inc. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
Assets
Current assets:
Cash and cash equivalents
Accounts receivable
Short-term investments
Prepaid expenses and other current assets
Restricted cash
Total current assets
Property and equipment, net
Deferred tax assets
Restricted cash
Long-term investments
Operating lease right-of-use assets
Other non-current assets
Total assets
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Income taxes payable
Deferred revenue
Operating lease liabilities
Total current liabilities
Deferred rent, net of current portion
Long-term debt, net of discount
Income taxes payable, net of current portion
Deferred revenue, net of current portion
Operating lease liabilities, net of current portion
Total liabilities
Shareholders’ equity:
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders’ equity

Comments